<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7252082\results\search\drug\results.xml">
  <result pre="and efficacy are being conducted. Camostat mesilate/nafamostat mesilateTreatment for pancreatitis" exact="Serine" post="protease/TMPRSS2 inhibitor â€¢In mice, camostat mesilate dosed at concentrations"/>
  <result pre="Camostat mesilate/nafamostat mesilateTreatment for pancreatitis Serine protease/TMPRSS2 inhibitor â€¢In mice," exact="camostat" post="mesilate dosed at concentrations akin to the clinically achievable"/>
  <result pre="infection from 100% to 30â€&quot;35%. â€¢In vitro studies demonstrated that" exact="camostat" post="mesilate can block SARS-COV-2 entry into human lung cells"/>
  <result pre="clinical practice. A randomized, placebo-controlled trial exploring the impact of" exact="camostat" post="mesilate on COVID-19 Infection has begun recruiting patients (nÂ"/>
  <result pre="=Â 180) to provide key insights into the safety of" exact="camostat" post="mesilate in COVID-19 patients. Favipiravir (favilavir)Approved drug for novel"/>
  <result pre="case series of hospitalised COVID-19 patients (nÂ =Â 138) used" exact="azithromycin" post="for antibacterial coverage,31 although the available evidence is insufficient"/>
  <result pre="evidence is insufficient to establish safety and benefit of adjunct" exact="azithromycin" post="use in patients with COVID-19. Risk of cardiac arrhythmias"/>
  <result pre="of cardiac arrhythmias (such as QT prolongation) and psychiatric disturbances" exact="Azithromycin" post="causes additive toxicity with amiodarone hydrochloride ChloroquineAntimalarial agent May"/>
  <result pre="QT prolongation) and psychiatric disturbances Azithromycin causes additive toxicity with" exact="amiodarone" post="hydrochloride ChloroquineAntimalarial agent May interfere with ACE2 receptor glycosylation"/>
  <result pre="is available to substantiate the efficacy and possible benefits of" exact="chloroquine" post="in patients with COVID-19.36 â€¢Although the pharmacokinetics and toxicity"/>
  <result pre="patients with COVID-19.36 â€¢Although the pharmacokinetics and toxicity profile of" exact="chloroquine" post="is well-established in malaria treatment (the use of high"/>
  <result pre="use); caution in patients with glucose-6-phosphate-dehdrogenase deficiency and diabetic patients." exact="Chloroquine" post="may increase ciclosporin's concentration and risk of toxicity (creatinine"/>
  <result pre="(creatinine concentration may increase even with low doses of ciclosporin);" exact="cimetidine" post="reduces metabolism of chloroquine Hydroxychloroquine Hydroxychloroquine (hydroxyl analog of"/>
  <result pre="even with low doses of ciclosporin); cimetidine reduces metabolism of" exact="chloroquine" post="Hydroxychloroquine Hydroxychloroquine (hydroxyl analog of chloroquine) has similar antiviral"/>
  <result pre="with low doses of ciclosporin); cimetidine reduces metabolism of chloroquine" exact="Hydroxychloroquine" post="Hydroxychloroquine (hydroxyl analog of chloroquine) has similar antiviral mechanism"/>
  <result pre="low doses of ciclosporin); cimetidine reduces metabolism of chloroquine Hydroxychloroquine" exact="Hydroxychloroquine" post="(hydroxyl analog of chloroquine) has similar antiviral mechanism as"/>
  <result pre="findings from China reported good prognosis for patients who received" exact="hydroxychloroquine" post="sulfate 400 mg daily for 5 days.39 â€¢A randomized,"/>
  <result pre="immunoglobulin, with or without corticosteroids) vs standard treatment plus oral" exact="hydroxychloroquine" post="in patients in COVID-19 patients (nÂ =Â 68) from"/>
  <result pre="care alone (nÂ =Â 84) vs standard care plus oral" exact="hydroxychloroquine" post="(nÂ =Â 97) but found no significant difference in"/>
  <result pre="but it may interact with drugs affecting blood glucose concentration" exact="Hydroxychloroquine" post="with azithromycin See above for information about each agent."/>
  <result pre="may interact with drugs affecting blood glucose concentration Hydroxychloroquine with" exact="azithromycin" post="See above for information about each agent. â€¢Preliminary findings"/>
  <result pre="nonrandomized study showed that patients (nÂ =Â 36) who received" exact="hydroxychloroquine" post="with azithromycin had a higher percentage of negative PCR"/>
  <result pre="showed that patients (nÂ =Â 36) who received hydroxychloroquine with" exact="azithromycin" post="had a higher percentage of negative PCR results in"/>
  <result pre="in nasopharyngeal samples at day 6 than those who received" exact="hydroxychloroquine" post="alone.36 â€¢A pilot uncontrolled non-comparative observational study in Marseille,"/>
  <result pre="non-comparative observational study in Marseille, France investigated the efficacy of" exact="hydroxychloroquine" post="with azithromycin in mild COVID-19 patients (nÂ =Â 80),"/>
  <result pre="study in Marseille, France investigated the efficacy of hydroxychloroquine with" exact="azithromycin" post="in mild COVID-19 patients (nÂ =Â 80), and revealed"/>
  <result pre="other drugs causing QT prolongation.43 â€¢Another study recently reported that" exact="azithromycin" post="used alone has caused QT prolongation,44 demonstrating the need"/>
  <result pre="Hydroxychloroquine/chloroquine use was not associated with a safety signal while" exact="azithromycin" post="used alone was associated with TdP/QT prolongation. See above"/>
  <result pre="combination. See above for information about each agent. Other agentsb" exact="Ibuprofen" post="and other NSAIDS â€¢A letter published in The Lancet"/>
  <result pre="Respir Med46 reported a link between use of thiazolidinediones and" exact="ibuprofen" post="and an increased ACE2 expression, resulting in worsened outcomes"/>
  <result pre="is no compelling published evidence to support an association between" exact="ibuprofen" post="and poor outcomes in patients diagnosed with COVID-19. â€¢On"/>
  <result pre="with NSAIDs, increasing the risk of hyperkalaemia and renal impairment" exact="Nitric oxide" post="(inhaled) A selective pulmonary vasodilator with demonstrated benefit in"/>
  <result pre="â€¢There is in vitro evidence of direct antiviral activity of" exact="nitric oxide" post="against SARS-CoV.53 â€¢Clinical trials evaluating the use of inhaled"/>
  <result pre="oxide against SARS-CoV.53 â€¢Clinical trials evaluating the use of inhaled" exact="nitric oxide" post="in the management of mild-to-moderate COVID-19 are underway.54 â€¢At"/>
  <result pre="against SARS-CoV-2 â€¢An in vitro study showed a potential for" exact="ivermectin" post="against SARS-CoV-2.55 Safe at a dose for anti-parasitic use,"/>
  <result pre="pandemic of fake â€œessentialâ€� medicines (including the COVID-19 candidate drug" exact="chloroquine" post="and hydroxychloroquine) and other medical supplies. Since COVID-19 was"/>
  <result pre="producers of medical supplies, China and India, following lockdown. After" exact="hydroxychloroquine" post="was claimed effective for COVID-19 treatment, there was a"/>
  <result pre="panic. A classic example is the recent media announcements that" exact="hydroxychloroquine" post="and chloroquine are the â€œgame changersâ€� and potential cure"/>
  <result pre="classic example is the recent media announcements that hydroxychloroquine and" exact="chloroquine" post="are the â€œgame changersâ€� and potential cure for COVID-19,"/>
  <result pre="inappropriate stockpiling and use by the public. Inappropriate stockpiling of" exact="hydroxychloroquine" post="has also resulted in substantial shortages affecting arthritis or"/>
  <result pre="Â°C, and widely circulated myths on social media around taking" exact="Ibuprofen" post="(Advil, Motrin), naproxen (Aleve) and other non-steroidal anti-inflammatory drugs"/>
  <result pre="circulated myths on social media around taking Ibuprofen (Advil, Motrin)," exact="naproxen" post="(Aleve) and other non-steroidal anti-inflammatory drugs (NSAIDs), vitamins: C,"/>
  <result pre="suggestions on the potential efficacy of certain drugs, such as" exact="chloroquine" post="and hydroxychloroquine, have resulted in hoarding of the drugs"/>
  <result pre="(TGA) implemented restrictions on the medical specialists that can initiate" exact="hydroxychloroquine" post="prescribing. Further to this, TGA has released a statement"/>
  <result pre="acute respiratory infections caused by 2019â€�nCoVChembiochem2020 9YaoT.T.QianJ.D.ZhuW.Y.WangY.WangG.Q.A systematic review of" exact="lopinavir" post="therapy for SARS coronavirus and MERS coronavirusâ€&quot;A possible reference"/>
  <result pre="Assoc2020 Feb 7e201585 32DevauxC.A.RolainJ.-M.ColsonP.RaoultD.New insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: what to expect for COVID-19?Int J Antimicrob"/>
  <result pre="expect for COVID-19?Int J Antimicrob Agents2020 Mar 1210593832171740 33ColsonP.RolainJ.-M.LagierJ.-C.BrouquiP.RaoultD.Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19Int J Antimicrob Agents5542020"/>
  <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
  <result pre="syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020 Mar 9ciaa237 35WangM.CaoR.ZhangL.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="emerged novel coronavirus (2019-nCoV) in vitroCell Res3032020 Mar26927132020029 36GautretP.LagierJ.-C.ParolaP.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="non-randomized clinical trialInt J Antimicrob Agents2020 Mar 2010594932205204 37RolainJ.-M.ColsonP.RaoultD.Recycling of" exact="chloroquine" post="and its hydroxyl analogue to face bacterial, fungal and"/>
  <result pre="Oct29730817629679 38CortegianiA.IngogliaG.IppolitoM.GiarratanoA.EinavS.A systematic review on the efficacy and safety of" exact="chloroquine" post="for the treatment of COVID-19J Crit CareS0883â€&quot;9441202020 Mar 103039030397"/>
  <result pre="COVID-19J Crit CareS0883â€&quot;9441202020 Mar 103039030397 39Chen JunL.D.LiuLiLiuPingXuA pilot study of" exact="hydroxychloroquine" post="in treatment of patients with common coronavirus disease-19 (COVID-19)J"/>
  <result pre="common coronavirus disease-19 (COVID-19)J Zhejiang Univ (Med Sci)49120200-0 40ChenZ.HuJ.ZhangZ.Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: results of a randomized clinical"/>
  <result pre="a randomized clinical trialMedrxiv202010.1101/2020.03.22.20040758 41MahevasM.TranV.-T.RoumierM.No evidence of clinical efficacy of" exact="hydroxychloroquine" post="in patients hospitalized for COVID-19 infection with oxygen requirement:"/>
  <result pre="target trialmedRxiv202010.1101/2020.04.10.200606992020.2004.2010.20060699 42GautretP.LagierJ.-C.ParolaP.Clinical and microbiological effect of a combination of" exact="hydroxychloroquine" post="and azithromycin in 80 COVID-19 patients with at least"/>
  <result pre="42GautretP.LagierJ.-C.ParolaP.Clinical and microbiological effect of a combination of hydroxychloroquine and" exact="azithromycin" post="in 80 COVID-19 patients with at least a six-day"/>
  <result pre="1110166332289548 43ChorinE.DaiM.ShulmanE.The QT interval in patients with COVID-19 treated with" exact="hydroxychloroquine" post="and azithromycinNat Med202010.1038/s41591-020-0888-2 44SarayaniA.CicaliB.HenriksenC.H.BrownJ.D.Safety signals for QT prolongation or"/>
  <result pre="signals for QT prolongation or Torsades de Pointes associated with" exact="azithromycin" post="with or without chloroquine or hydroxychloroquineRes Soc Adm Pharm2020"/>
  <result pre="or Torsades de Pointes associated with azithromycin with or without" exact="chloroquine" post="or hydroxychloroquineRes Soc Adm Pharm2020 Apr 19S1551-7411(20)30391-0 45collab: US"/>
  <result pre="council on hypertension on ACE-inhibitors and angiotensin receptor blockershttps://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang2020 52GebistorfF.KaramO.WetterslevJ.AfshariA.Inhaled" exact="nitric oxide" post="for acute respiratory distress syndrome (ARDS) in children and"/>
  <result pre="Virol7932005 Feb1966196915650225 54BiospaceBiospace mallinckrodt evaluates the potential role for inhaled" exact="nitric oxide" post="to treat COVID-19 associated lung complications, engages with scientific,"/>
  <result pre="controlled clinical study to evaluate the efficacy of ASC09F and" exact="Ritonavir" post="for 2019-nCoV Pneumonia. ClinicalTrials.gov Identifier: NCT04261270https://clinicaltrials.gov/ct2/show/NCT04261270?term=NCT04261270&amp;amp;draw=2&amp;amp;rank=12020 58LythgoeM.P.MiddletonP.Ongoing clinical trials"/>
  <result pre="of AustraliaCOVID-19 New Information/Update2020https://www.guild.org.au/resources/business-operations/covid-19 66Therapeutic Goods AdministrationNew Restrictions on Prescribing" exact="Hydroxychloroquine" post="for COVID-192020https://www.tga.gov.au/alert/new-restrictions-prescribing-hydroxychloroquine-covid-19 67Health DoEnsuring Continued Access to Medicines during"/>
 </snippets>
</snippetsTree>
